GeoVax Company
GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.
Technology:
Viral Vectors
Industry:
Viral Vectors
Headquarters:
Smyrna, Georgia, United States
Founded Date:
1988-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
1
Total Funding:
28048841
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-01-14
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership